Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Validation of the 15-Item Myasthenia Gravis Quality of Life Questionnaire (Mg-Qol15) Persian Version Publisher Pubmed



Ostovan VR1 ; Fatehi F1 ; Davoudi F2 ; Nafissi S1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Iranian Center of Neurological Research, Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, North Kargar Street, Tehran, 14117-13135, Iran
  2. 2. Department of Community Medicine, Iran University of Medical sciences, Tehran, Iran

Source: Muscle and Nerve Published:2016


Abstract

Introduction: The 15-item Myasthenia Gravis Quality Of Life (MG-QOL15) questionnaire is a valid and reliable instrument for evaluation of myasthenia gravis (MG) associated disability. Our study aim was to assess its validity and reliability in the Iranian population. Methods: We enrolled 75 consecutive patients with established MG at 2 neuromuscular clinics in Tehran, Iran. All 75 patients completed the Persian MG-QOL15 and SF-36 questionnaire initially, and 30 filled out the MG-QOL15 questionnaire from 2 to 4 weeks after the initial visit. Concurrent and construct validity, internal consistency, and test–retest repeatability of the questionnaire were evaluated. Results: The Persian MG-QOL15 showed satisfactory internal consistency (Cronbach alpha = 0.94) and test–retest reliability(r = 0.98; P < 0.001). It also demonstrated adequate concurrent and construct validity; moreover, the MG-QOL15 scores were higher in patients with more severe conditions. Conclusions: The Persian MG-QOL15 is a valid and reliable questionnaire for determination of quality of life in Iranian MG patients. Muscle Nerve 54: 65–70, 2016. © 2015 Wiley Periodicals, Inc.
Other Related Docs
5. Psychometric Validation of the Persian Version of the Lysholm Score, Orthopaedic Journal of Sports Medicine (2025)
11. Health State Utilities for Patient’S Current Health From Bipolar Type I Disorder, Journal of Mental Health Policy and Economics (2018)